Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
1. 183204-72-0
2. Tipiracil Hcl
3. Tipiracil (hydrochloride)
4. Tipiracil Hydrochloride [usan]
5. Tas-1-462
6. 4h59klq0a4
7. 5-chloro-6-((2-iminopyrrolidin-1-yl)methyl)pyrimidine-2,4(1h,3h)-dione Hydrochloride
8. Chembl65375
9. Ma-1 Hydrochloride
10. Tpi
11. Unii-4h59klq0a4
12. Tipiracil.hcl
13. 5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]pyrimidine-2,4(1h,3h)-dione Hydrochloride
14. Tipiracilhydrochloride
15. Tipiracil Monohydrochloride
16. 5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]-1h-pyrimidine-2,4-dione;hydrochloride
17. Schembl1682924
18. Chebi:90877
19. Ex-a882
20. Dtxsid001027748
21. Amy25415
22. Bcp06245
23. Ex-a1393
24. Hy-a0063
25. Tipiracil Hydrochloride (jan/usan)
26. Tipiracil Hydrochloride [mi]
27. Mfcd01571384
28. S3731
29. Tipiracil Hydrochloride [jan]
30. Akos027427002
31. Ccg-267234
32. Cs-1637
33. Tipiracil Hydrochloride [who-dd]
34. 2,4(1h,3h)-pyrimidinedione,5-chloro-6-[(2-imino-1-pyrrolidinyl)methyl]-, Hydrochloride (1:1)
35. Ac-30634
36. As-56082
37. Tipiracil Hydrochloride, >=98% (hplc)
38. Db-065426
39. Ft-0700247
40. Tipiracil Hydrochloride [orange Book]
41. A13098
42. D10467
43. Lonsurf Component Tipiracil Hydrochloride
44. A847265
45. S-95005 Component Tipiracil Hydrochloride
46. Tas-102 Component Tipiracil Hydrochloride
47. Tipiracil Hydrochloride Component Of Lonsurf
48. J-690251
49. Q27162848
50. 5-chloro-6-(1-(2-iminopyrrolidinyl)methyl)uracil Hydrochloride
51. 5-chloro-6-(1-(2-iminopyrrolidinyl)-methyl)uracil Hydrochloride
52. 2,4(1h,3h)-pyrimidinedione,5-chloro-6-[(2-imino-1-pyrrolidinyl)methyl] Hydrochloride
53. 5-chloro-6-((2-iminopyrrolidin-1-yl)methyl)pyrimidine-2,4(1h,3h)-dione Hcl
54. 5-chloro-6-((2-iminopyrrolidin-1-yl)methyl)pyrimidine-2,4(1h,3h)-dionehydrochloride
55. 5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1h,3h)-pyrimidinedione Hydrochloride
56. 5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4-(1h,3h)-pyrimidinedione Hydrochloride
57. 1-[(5-chloro-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)methyl]pyrrolidin-2-iminium Chloride
58. 2,4(1h,3h)-pyrimidinedione, 5-chloro-6-((2-imino-1-pyrrolidinyl)methyl)-, Hydrochloride (1:1)
59. 5-chloro-6-((2-iminopyrrolidin-1-yl)methyl)pyrimidine-2,4(1h,3h)-dione Hydrochloride;tipiracil Hcl
60. 5-chloro-6-(2-imino-pyrrolidin-1-yl)methyl-2,4(1h,3h)-pyrimidinedione Hydrochloride
Molecular Weight | 279.12 g/mol |
---|---|
Molecular Formula | C9H12Cl2N4O2 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 2 |
Exact Mass | 278.0337310 g/mol |
Monoisotopic Mass | 278.0337310 g/mol |
Topological Polar Surface Area | 85.3 Ų |
Heavy Atom Count | 17 |
Formal Charge | 0 |
Complexity | 404 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33217
Submission : 2018-09-28
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-09-25
Pay. Date : 2019-07-25
DMF Number : 33926
Submission : 2019-08-08
Status : Active
Type : II
Date of Issue : 2019-10-07
Valid Till : 2022-06-12
Written Confirmation Number : WC-0372
Address of the Firm :
NDC Package Code : 70225-1109
Start Marketing Date : 2018-12-19
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28368
Submission : 2014-11-25
Status : Active
Type : II
Registrant Name : Synex Co., Ltd.
Registration Date : 2018-12-26
Registration Number : Su487-2-ND
Manufacturer Name : Taiho Pharmaceutical Co., Ltd. Saitama Plant
Manufacturer Address : 200-22 Motohara, Kamikawa-machi, Kodama-gun, Saitama 367-0241, Japan
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-04-12
Pay. Date : 2019-02-14
DMF Number : 33578
Submission : 2019-02-19
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36239
Submission : 2023-11-20
Status : Active
Type : II
NDC Package Code : 68554-0119
Start Marketing Date : 2015-09-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-05-28
Pay. Date : 2019-04-22
DMF Number : 33787
Submission : 2019-04-18
Status : Active
Type : II
NDC Package Code : 59651-365
Start Marketing Date : 2024-01-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
Date of Issue : 2020-08-17
Valid Till : 2023-06-22
Written Confirmation Number : WC-0404
Address of the Firm :
NDC Package Code : 69575-4030
Start Marketing Date : 2021-12-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
Date of Issue : 2020-08-17
Valid Till : 2023-06-22
Written Confirmation Number : WC-0404A2
Address of the Firm :
NDC Package Code : 69575-4030
Start Marketing Date : 2021-12-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?